投稿信息
投稿信息
員@2x.png)
審稿費(fèi)用
暫無數(shù)據(jù)
版面費(fèi)用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量5.00% (2022年為1.24%)
自引率
8.3 %
年文章數(shù)
1628
期刊官網(wǎng)
點(diǎn)擊查看
(點(diǎn)擊次數(shù):7352)
投稿鏈接
點(diǎn)擊查看
(點(diǎn)擊次數(shù):2448次)
作者需知
暫無數(shù)據(jù)
NCBI查詢
偏重的研究方向
暫無數(shù)據(jù)
期刊簡(jiǎn)介
稿件收錄要求
稿件收錄要求
Drug Safety is the only international review journal covering the disciplines of pharmacovigilance, pharmacoepidemiology and benefit-risk assessment. Drug Safety's structured programme of peer reviewed commissioned articles ensures comprehensive coverage of all topics. High quality original research focusing on the clinical implications of drug treatment safety issues is also published. Drug Safety specialises in definitive reviews on the epidemiology, clinical features, prevention and management of adverse effects of individual drugs or drug classes. Benefit-risk assessments provide you with an in-depth review of adverse effect and efficacy data for a drug in a specific disease. Drug Safety also features reviews covering drug use in particular 'at-risk' patient groups, and concept reviews of current thinking in pharmacovigilance, risk minimisation and medication error prevention. Articles focus on the practical aspects of ensuring the safest possible use of drugs, including analysis and interpretation of adverse effects, post-marketing surveillance and pharmacoepidemiology.
常用鏈接
期刊論壇
|
中國SCI論文
|
期刊介紹
|
投稿信息
|
雜志官網(wǎng)
|
投稿鏈接
|
作者需知
|
PMC鏈接
|
Pubmed全文檢索
